Key result
Recombinant hirudin is a suitable anticoagulant for studying platelet functions, causing significantly lower spontaneous platelet aggregation compared to heparin or citrate without altering reactions.
Why the study?
Does recombinant hirudin alter platelet functions compared to heparin or citrate in anticoagulated blood?
Does recombinant hirudin alter platelet functions compared to heparin or citrate in anticoagulated blood?
Recombinant hirudin is a suitable anticoagulant for in vitro platelet function studies as it does not alter platelet reactions or ionized calcium concentrations.
Answers are grounded in this paper and cite their sources.
Recombinant hirudin may suit animal platelet assays better than heparin; leaves open human validation before any clinical use.
The influence of genetically engineered recombinant hirudin (r-hirudin) on platelet functions was studied. Depending on the concentration, r-hirudin inhibits the thrombin-induced aggregation and 14C-serotonin secretion to the same extent as native hirudin. Comparative studies in blood anticoagulated by r-hirudin, heparin or citrate show a significantly lower spontaneous platelet aggregation in r-hirudinized blood. The extent of the ADP-induced aggregation is nearly the same in r-hirudinized, heparinized or citrated plasma. In r-hirudinized plasma, however, aggregation is reversible. In contrast to heparinized or citrated plasma, adrenaline causes only a very slight aggregation in r-hirudinized plasma. ADP- or adrenaline-induced secretion of 14C-serotonin do not occur in r-hirudinized plasma. The collagen- as well as the PAF-induced aggregation and 14C-serotonin release in hirudinized plasma do not differ significantly from those in heparinized or citrated plasma. r-Hirudin is a suitable anticoagulant for studying platelet functions because it does not produce any alterations in platelet reactions and does not provoke any changes in the ionized calcium concentration in blood.
No takes yet. Share an insight, caveat, or question.
Glusa et al. (2009) studied this question. Recombinant hirudin (r-hirudin) vs. Heparin or citrate was evaluated on Platelet aggregation and 14C-serotonin secretion. Recombinant hirudin is a suitable anticoagulant for studying platelet functions, causing significantly lower spontaneous platelet aggregation compared to heparin or citrate without altering reactions.
Synapse has enriched 10 related papers. Consider them for comparative context: